• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

内耳药物递送:策略及其对感音神经性听力损失的治疗意义。

Drug delivery to the inner ear: strategies and their therapeutic implications for sensorineural hearing loss.

机构信息

University Hospital Prince of Asturias, University of Alcalá, Madrid, Spain.

出版信息

Curr Drug Deliv. 2012 May;9(3):231-42. doi: 10.2174/156720112800389098.

DOI:10.2174/156720112800389098
PMID:22283653
Abstract

Hearing aids or cochlear implants constitute almost exclusively the treatment options currently available to patients suffering from sensorineural hearing loss and related conditions, such as noise-induced hearing loss, ototoxicity or autoimmune inner ear disease. While some systemic treatments exist, they generally exert adverse secondary effects and their efficacy is hampered by the blood-cochlear barrier that limits drug access to the inner ear. Hence, the new therapies that are being developed for hearing loss focus on strategies for direct drug delivery to the inner ear. The passive and active methods for local delivery can be categorized into two general groups: intratympanic or intracochlear. The intratympanic approach is a non-invasive method that preserves hearing and takes advantage of the permeability of the round window to gain access to the cochlea. However, this technique is limited by not knowing the dose of the drug that reaches the cochlea, (a handicap which might be overcome by the use of tagged drugs). While direct access to the inner ear by intracochlear administration avoids this problem, this method requires surgery. Currently, laboratory animals are being used to explore which therapeutic approaches are best suited to address this problem. These include cochleostomy and the insertion of devices that pump drugs into the inner ear without inducing cochlear damage. In this article, we review the different techniques under evaluation in animal models of deafness, and their potential use for drug delivery and treatment of human inner ear diseases.

摘要

助听器或人工耳蜗几乎是目前用于治疗感音神经性听力损失和相关疾病(如噪声性听力损失、耳毒性或自身免疫性内耳疾病)的唯一选择。虽然存在一些全身治疗方法,但它们通常会产生不良反应,并且由于血迷路屏障限制了药物进入内耳,其疗效受到阻碍。因此,目前正在开发的治疗听力损失的新疗法侧重于将药物直接递送到内耳的策略。局部给药的被动和主动方法可以分为两类:鼓室内或耳蜗内。鼓室内方法是非侵入性方法,可保留听力,并利用圆窗的通透性进入耳蜗。然而,这种技术受到不知道到达耳蜗的药物剂量的限制(可以通过使用标记药物来克服这个问题)。虽然通过耳蜗内给药直接进入内耳可以避免这个问题,但这种方法需要手术。目前,正在使用实验室动物来探索哪种治疗方法最适合解决这个问题。这些方法包括耳蜗造口术和插入将药物泵入内耳而不引起耳蜗损伤的装置。本文综述了在耳聋动物模型中评估的不同技术及其在药物输送和治疗人类内耳疾病方面的潜在用途。

相似文献

1
Drug delivery to the inner ear: strategies and their therapeutic implications for sensorineural hearing loss.内耳药物递送:策略及其对感音神经性听力损失的治疗意义。
Curr Drug Deliv. 2012 May;9(3):231-42. doi: 10.2174/156720112800389098.
2
Inner ear drug delivery for auditory applications.用于听觉应用的内耳药物递送。
Adv Drug Deliv Rev. 2008 Dec 14;60(15):1583-99. doi: 10.1016/j.addr.2008.08.001. Epub 2008 Sep 21.
3
Nanodelivery of antioxidant Agents: A promising strategy for preventing sensorineural hearing loss.抗氧化剂的纳米递送:预防感音神经性听力损失的一种有前景的策略。
Eur J Pharm Biopharm. 2024 Sep;202:114393. doi: 10.1016/j.ejpb.2024.114393. Epub 2024 Jul 9.
4
Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss.用于治疗感音神经性听力损失的纳米基内耳给药系统的进展
Adv Drug Deliv Rev. 2017 Jan 1;108:2-12. doi: 10.1016/j.addr.2016.01.004. Epub 2016 Jan 12.
5
Recent advances in local drug delivery to the inner ear.内耳局部药物递送的最新进展。
Int J Pharm. 2015 Oct 15;494(1):83-101. doi: 10.1016/j.ijpharm.2015.08.015. Epub 2015 Aug 7.
6
[Local drug therapy for inner ear hearing loss].[内耳性听力损失的局部药物治疗]
HNO. 2015 Jun;63(6):396-401. doi: 10.1007/s00106-014-2890-9.
7
Inner ear drug delivery: Recent advances, challenges, and perspective.内耳药物递送:最新进展、挑战与展望。
Eur J Pharm Sci. 2019 Jan 1;126:82-92. doi: 10.1016/j.ejps.2018.05.020. Epub 2018 May 21.
8
Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier.将治疗药物递送至内耳:血迷路屏障的挑战。
Sci Transl Med. 2019 Mar 6;11(482). doi: 10.1126/scitranslmed.aao0935.
9
Innovative pharmaceutical approaches for the management of inner ear disorders.用于内耳疾病管理的创新药物方法。
Drug Deliv Transl Res. 2018 Apr;8(2):436-449. doi: 10.1007/s13346-017-0384-5.
10
Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications.内耳的药代动力学原理:药物性质对鼓室内应用的影响。
Hear Res. 2018 Oct;368:28-40. doi: 10.1016/j.heares.2018.03.002. Epub 2018 Mar 11.

引用本文的文献

1
Hearing loss during chemotherapy: prevalence, mechanisms, and protection.化疗期间的听力损失:患病率、机制及保护
Am J Cancer Res. 2024 Sep 25;14(9):4597-4632. doi: 10.62347/OKGQ4382. eCollection 2024.
2
Pericytes of Stria Vascularis Are Targets of Cisplatin-Induced Ototoxicity: New Insights into the Molecular Mechanisms Involved in Blood-Labyrinth Barrier Breakdown.血管纹周细胞是顺铂诱导耳毒性的靶点:血迷路屏障破坏相关分子机制的新见解。
Int J Mol Sci. 2022 Dec 13;23(24):15790. doi: 10.3390/ijms232415790.
3
Drug distribution along the cochlea is strongly enhanced by low-frequency round window micro vibrations.
低频圆窗微振动可显著增强耳蜗内药物分布。
Drug Deliv. 2021 Dec;28(1):1312-1320. doi: 10.1080/10717544.2021.1943059.
4
Effect and Biocompatibility of a Cross-Linked Hyaluronic Acid and Polylactide--glycolide Microcapsule Vehicle in Intratympanic Drug Delivery for Treating Acute Acoustic Trauma.交联透明质酸和聚乳酸-乙醇酸微囊载体经鼓室内给药治疗急性声创伤的效果和生物相容性。
Int J Mol Sci. 2021 May 27;22(11):5720. doi: 10.3390/ijms22115720.
5
Local Drug Delivery to the Entire Cochlea without Breaching Its Boundaries.在不破坏耳蜗边界的情况下对整个耳蜗进行局部药物递送。
iScience. 2020 Mar 27;23(3):100945. doi: 10.1016/j.isci.2020.100945. Epub 2020 Feb 26.
6
Solid Lipid Nanoparticles Loaded with Glucocorticoids Protect Auditory Cells from Cisplatin-Induced Ototoxicity.负载糖皮质激素的固体脂质纳米粒可保护听觉细胞免受顺铂诱导的耳毒性。
J Clin Med. 2019 Sep 14;8(9):1464. doi: 10.3390/jcm8091464.
7
Drug Diffusion Along an Intact Mammalian Cochlea.药物沿完整哺乳动物耳蜗的扩散。
Front Cell Neurosci. 2019 Apr 26;13:161. doi: 10.3389/fncel.2019.00161. eCollection 2019.
8
Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier.将治疗药物递送至内耳:血迷路屏障的挑战。
Sci Transl Med. 2019 Mar 6;11(482). doi: 10.1126/scitranslmed.aao0935.
9
Interplay between Nutrition and Hearing Loss: State of Art.营养与听力损失的相互作用:最新研究进展。
Nutrients. 2018 Dec 24;11(1):35. doi: 10.3390/nu11010035.
10
Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice.耳道造口术作为一种向成年和新生小鼠内耳局部给药的手术方法。
J Vis Exp. 2018 May 25(135):57351. doi: 10.3791/57351.